	US 11,717,490 B2
	Therapeutic nanocarrier system and methods of use
Yiota Gregoriou, Nicosia (CY); Gregoria Gregoriou, Nicosia (CY); and Andreas I. Constantinou, Chicago, IL (US)
Assigned to UNIVERSITY OF CYPRUS, Nicosia (CY)
Filed by UNIVERSITY OF CYPRUS, Nicosia (CY)
Filed on Jun. 4, 2021, as Appl. No. 17/339,339.
Claims priority of provisional application 63/035,415, filed on Jun. 5, 2020.
Prior Publication US 2021/0378978 A1, Dec. 9, 2021
Int. Cl. A61K 9/51 (2006.01); A61K 31/05 (2006.01); A61K 47/10 (2017.01)

CPC A61K 9/5146 (2013.01) [A61K 31/05 (2013.01); A61K 47/10 (2013.01)]

3 Claims

1. A nanoparticle comprising a poloxamer surfactant, a Vitamin E TPGS and an anticancer compound wherein the poloxamer surfactant is poloxamer 407 and the anticancer compound is resveratrol which further comprises a fluorophore.